HUTCHMED (China) (HCM) Change in Working Capital (2020 - 2021)

HUTCHMED (China)'s (HCM) quarterly Change in Working Capital came in at $1.5 million in Q1 2021, up 187.08% year-on-year from $511000.0 in Q1 2020, and up 187.08% on a QoQ basis from $511000.0 in Q1 2020.

HUTCHMED (China) (HCM) Change in Working Capital (2020 - 2021) Analysis & Trends

HUTCHMED (China) (HCM) has 2 years of Change in Working Capital data on file, last reported at $1.5 million in Q1 2021.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Change in Working Capital (Qtr)
1 Haleon 87.22 Bn 85.35 Bn - -
2 Teva Pharmaceutical Industries 39.60 Bn 35.87 Bn 1.97 Bn -617.00 Mn
3 Zoetis 31.46 Bn 29.52 Bn 1.62 Bn -
4 Takeda Pharmaceutical 26.49 Bn 22.44 Bn 4.39 Bn -
5 United Therapeutics 23.03 Bn 20.88 Bn 648.10 Mn -
6 Universe Pharmaceuticals 23.03 Bn -10.56 Bn - -
7 Viatris 20.90 Bn 19.09 Bn 1.16 Bn -
8 Neurocrine Biosciences 17.50 Bn 16.19 Bn 800.70 Mn -
9 Elanco Animal Health 12.33 Bn 11.91 Bn 785.00 Mn -
10 HUTCHMED (China) 241.90 Mn 243.61 Mn - -

Historic Data

Download Data
DateValue
Mar 31, 2021 1.47 Mn
Mar 31, 2021 1.47 Mn
Mar 31, 2020 511,000.00
Mar 31, 2020 511,000.00